Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: allogeneic

Regeneus – stem cell therapy

Posted on by

Regeneus is a biotech company developing and commercializing proprietary technologies for the preparation of cell therapies for the treatment of musculoskeletal and other inflammatory conditions in humans and animals.

Regeneus – stem cell therapy

regeneus Continue reading →

Posted in Biotech Companies, Biotech Companies Australia | Tagged AdiCell, adipocyte, adipocytes, adipose, adipose tissue, adipose-derived cell, adipose-derived cells, adipose-derived regenerative cell, adipose-derived regenerative cells, allogeneic, anti-inflammatory, ASX code, Australian Stock Exchange, autologous cell therapy, Barry Sechos, Cell Therapies, Cell Therapy, CryoShot, Graham Vesey, HiQCell, HiQCell stem cell therapy, human musculoskeletal condition, human musculoskeletal conditions, John Martin, mesenchymal stem cell, Mesenchymal Stem Cells, MSC, MSCs, musculoskeletal, musculoskeletal condition, musculoskeletal conditions, regenerative capacities, regenerative capacity, regenerative cell, regenerative cells, regenerative medicine, Regeneus, Regeneus - stem cell therapy, RGS, Roger Aston, stem cell, Stem Cell Therapies, Stem Cell Therapy, stem cells

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress